# Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

> **NCT03718234** · PHASE1 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 11 (actual)

## Conditions studied

- Congenital Adrenal Hyperplasia
- Hyperplasia
- Adrenal Hyperplasia
- Congenital Disorders
- Adrenocortical Hyperfunction
- Disorders of Sex Development
- Urogenital Abnormalities
- Genetic Diseases, Inborn
- Steroid Metabolic Diseases, Inborn
- Adrenal Gland Disease
- Hydrocortisone

## Interventions

- **DRUG:** Subcutaneous hydrocortisone

## Key facts

- **NCT ID:** NCT03718234
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718234, "Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03718234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*